The team
Disperazol’s team is expereinced, with an established track record of long term collaboration and success.
-
Prof Michael Givskov
Head of Science
Inventor of Disperazol.
40 years experience in research and technology start-ups, as research leader and entrepreneur.
Founded and manages the Costerton Biofilm Center (Denmark) and co-founded the SCELSE Research Centre (Singapore).
-
Dr Michael Graz
CEO
30 years of experience in medical technology and biotechnology start ups and SMEs.
Has previously obtained Orphan Designation for a non traditional antimicrobial for which he raised USD15 Mn in follow-on funding for antibiotic development.
-
Assoc Prof Katrine Qvortrup
Head of Chemistry
Inventor of Disperazol.
Involved in several drug discovery projects.
Group Leader in the Chemical Biology section of the Chemistry Department at the Technical University, Denmark.
-
Prof MD Claus Moser
Head of Clinical Science
Chief Physician at Rigshospitalet in Copenhagen, Denmark.
Specialised in clinical microbiology.
Borregaard Clinical Scientist Fellowship from Novo Nordic Foundation in 2017.
-
Prof Tim Tolker Nielsen
Head of fundamental research
Inventor of Disperazol.
-
Dr Stewart Clark
Regulatory Advisor
-
Assoc Prof Louise D. Hultqvist
Inventor of Disperazol.
Dr Charlotte U. Jansen
Assoc Prof Jens Bo Andersen
Inventor of Disperazol.
Assoc Prof Carl Martin Nilsson
Inventor of Disperazol.
Assoc Prof Tim H. Jakobsen
Inventor of Disperazol.
Prof. Thomas E. Nielsen
Inventor of Disperazol.
-
Chief Surgeon MD, PhD Klaus Kirketerp-Møller
Copenhagen Wound Healing Center, Department of Dermatology and Wounds, Bispebjerg University Hospital and Steno Diabetes Center Copenhagen.
